Nivolumab in combination with ipilimumab for treating advanced melanoma

  • Technology appraisal guidance
  • TA400
  • Published: 

History

Documents created during the development process.

Final appraisal determination

Invitation to participate

Provisional matrix (pre-referral) - March 2015

Melanoma (advanced, unresectable, metastatic) - nivolumab [ID846], [ID847], [ID848]: draft scope for consultation (pre-referral) - March 2015